| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/14/2004 | EP1407008A2 Influenza vaccine composition |
| 04/14/2004 | EP1407007A1 Attenuated circovirus |
| 04/14/2004 | EP1407006A1 Method for the recovery and purification of poxviruses from infected cells |
| 04/14/2004 | EP1407004A2 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 04/14/2004 | EP1406930A2 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 04/14/2004 | EP1406928A1 Ntb-a, a surface molecule involved in natural killer cells activity |
| 04/14/2004 | EP1406916A2 Genes associated with mechanical stress, expression products therefrom, and uses thereof |
| 04/14/2004 | EP1406668A1 Composite oncolytic herpes virus vectors |
| 04/14/2004 | EP1406666A2 Adenoviral vectors with cell type specificity for mesenchymal cells |
| 04/14/2004 | EP1406658A1 Liquid formulation comprising cetuximab and a fatty acid ester of polyoxyethylene sorbitan |
| 04/14/2004 | EP1406657A1 A novel engineered superantigen for human therapy |
| 04/14/2004 | EP1406656A2 METHODS OF ADMINISTERING ANTI-TNF$g(a) ANTIBODIES |
| 04/14/2004 | EP1406653A2 T cell regulatory genes and methods of use thereof |
| 04/14/2004 | EP1406650A1 Use of poly-glu, tyr and t cells treated therewith for neuroprotection therapy |
| 04/14/2004 | EP1406644A2 Modified proteins, designer toxins, and methods of making thereof |
| 04/14/2004 | EP1406618A2 Use of nk-1 receptor antagonists with pyridinic structure for the treatment of brain, spinal or nerve injury |
| 04/14/2004 | EP0765392B1 Interleukin-5 specific recombinant antibodies |
| 04/14/2004 | CN1489630A HIV-like particles and use thereof |
| 04/14/2004 | CN1489628A Compounds and methods for treatment and diagnosis of chlamydial infection |
| 04/14/2004 | CN1489474A Monoclonal antibodies to CLFA protein and method of use in treating or preventing |
| 04/14/2004 | CN1489473A Silensed anti-CD 28 antibodies and use thereof |
| 04/14/2004 | CN1489472A Improved mycoplasma hyopneumoniae bacterin vaccine |
| 04/14/2004 | CN1488646A SARS virus S protein and N protein fusion protein, and preparation and use thereof |
| 04/14/2004 | CN1488645A Specific antibody IgY for anti SARS virus, and preparing method thereof and composition containing same and its use |
| 04/14/2004 | CN1488641A Polypeptide medicine for inhibiting SARS coronavirus, and derivatives and use thereof |
| 04/14/2004 | CN1145798C In vitro method for determining presence of hepatocellular carcindoma |
| 04/14/2004 | CN1145697C 治疗和诊断组合物 Therapeutic and diagnostic compositions |
| 04/14/2004 | CN1145639C Subunit respiratory syncytial virus vaccine preparation |
| 04/13/2004 | US6720409 Anti-human influenza virus antibody |
| 04/13/2004 | US6720310 Transfer method for specific cellular localization of nucleic acids |
| 04/13/2004 | US6720166 Non-a, non-b, non-c, non-c, non-d, non-e hepatitis reagents and methods for their use |
| 04/13/2004 | US6720146 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of ovarian cancer |
| 04/13/2004 | US6719983 VMP-like sequences of pathogenic Borrelia |
| 04/13/2004 | US6719981 Stable, attenuated rabies virus mutants and live vaccines thereof |
| 04/13/2004 | US6719980 Vaccines, diagnostic kits, veterinary medicine |
| 04/13/2004 | US6719979 Avian-paramyxovirus nucleotide sequences for use in the detection and treatment of avian viral diseases |
| 04/13/2004 | US6719978 Virus-like particles for the induction of autoantibodies |
| 04/13/2004 | US6719976 Administering monomolecular multi-epitope peptide prepared by binding t-cell epitope regions derived from different allergens |
| 04/13/2004 | US6719974 Heat shock protein-based vaccines and immunotherapies |
| 04/13/2004 | US6719972 Induce antigen specific apoptosis in activated t cells; ligands with monoclonal anti-ctla4 antibody that binds to an epitope of ctla4 |
| 04/13/2004 | US6719971 Method for making humanized antibodies |
| 04/13/2004 | US6718986 Mixed chimerism and tolerance |
| 04/13/2004 | CA2291608C Neurotrophic factor receptors |
| 04/13/2004 | CA2195076C Process for modifying the stability of antibodies |
| 04/13/2004 | CA2055695C Ca 195-like immunoreactive antigen from human amniotic fluid |
| 04/08/2004 | WO2004029617A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a (pde11a) |
| 04/08/2004 | WO2004029287A2 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 04/08/2004 | WO2004029274A2 Method for generating an immune response and reagents therefor |
| 04/08/2004 | WO2004029248A1 Tumor antigen protein and utilization thereof |
| 04/08/2004 | WO2004029208A2 Cell separation compositions and methods |
| 04/08/2004 | WO2004029207A2 Optimized fc variants and methods for their generation |
| 04/08/2004 | WO2004029206A2 Targeted cd1d molecules |
| 04/08/2004 | WO2004029093A2 Humanized anti-granulocyte mn-3 antibody and uses thereof |
| 04/08/2004 | WO2004029092A2 Antibody for adcc and inducing cytokine production |
| 04/08/2004 | WO2004029083A1 Hypoallergenic allergy vaccines based on the timothy grass pollen allergen phl p 7 |
| 04/08/2004 | WO2004028564A2 Treatment of pathologies which escape the immune response, using optimised antibodies |
| 04/08/2004 | WO2004028563A1 A vaccine enhancing the protective immunity to hepatitis c virus using plasmid dna and recombinant adenovirus |
| 04/08/2004 | WO2004028561A1 Method of inducing immune responses |
| 04/08/2004 | WO2004028479A2 Nouvelles compositions et methodes de traitement du psoriasis |
| 04/08/2004 | WO2004028478A2 Functional mutations in respiratory syncytial virus |
| 04/08/2004 | WO2004028473A2 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/08/2004 | WO2004028472A2 THERAPIES FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY USING INTERFERON-β |
| 04/08/2004 | WO2004028455A2 Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| 04/08/2004 | WO2004028442A2 Use of excipients to increase dna uptake by swine muscle cells |
| 04/08/2004 | WO2004028259A2 A method for stabilizing bioactive molecules |
| 04/08/2004 | WO2004020643A3 Regulated bacterial lysis for gene vaccine vector delivery and antigen release |
| 04/08/2004 | WO2004017992A3 Ptk7 protein involvement in carcinoma |
| 04/08/2004 | WO2004013172A3 Fragments of beta-amyloid as targets for vaccination against alzheimer disease |
| 04/08/2004 | WO2004013166A3 S. aureus antigene |
| 04/08/2004 | WO2004011637A3 Modified adamts4 molecules and method of use thereof |
| 04/08/2004 | WO2004009124A3 Ghrelin-carrier conjugates |
| 04/08/2004 | WO2004004687A3 Liposomal vaccine |
| 04/08/2004 | WO2004001004A3 Membrane associated tumor endothelium markers |
| 04/08/2004 | WO2003102207A3 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 04/08/2004 | WO2003100008A3 Neutralizing human anti-igfr antibody |
| 04/08/2004 | WO2003099860A8 Immunogenic composition and peptide sequences for prevention and treatment of an hsv condition |
| 04/08/2004 | WO2003092600A3 Site specific listeria integration vectors and methods for using the same |
| 04/08/2004 | WO2003089000A3 Anti-hiv composition, production method thereof and medicament |
| 04/08/2004 | WO2003087122A3 Sequences involved in the phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses, and the use of the same as medicaments |
| 04/08/2004 | WO2003087021A3 Nanoparticle delivery systems and methods of use thereof |
| 04/08/2004 | WO2003084979A3 Novel peptides and the application thereof in therapy |
| 04/08/2004 | WO2003083135A3 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2) |
| 04/08/2004 | WO2003076602A3 Use of l-$g(a)-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vivo |
| 04/08/2004 | WO2003076585A3 Controlled modulation of amino acid side chain length of peptide antigens |
| 04/08/2004 | WO2003076455A3 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein |
| 04/08/2004 | WO2003075956A3 Use of mixtures of lipopeptides for vaccine production |
| 04/08/2004 | WO2003066077A3 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 04/08/2004 | WO2003063893A3 Fgfr agonists |
| 04/08/2004 | WO2003046581A3 Methods for diagnosis and treatment of epithelial-derived cancers,such as colorectal cancers and kidney cancers |
| 04/08/2004 | WO2003014300A3 TRPS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 04/08/2004 | WO2003013599A3 Anti-coronavirus vaccine |
| 04/08/2004 | WO2002099074A8 Slc7s as modifiers of the p53 pathway and methods of use |
| 04/08/2004 | WO2002092008A3 Use of il-18 inhibitors for the treatement or prevention of sepsis |
| 04/08/2004 | WO2002091212A3 Modular personal device system |
| 04/08/2004 | WO2002083854A3 Antibodies to vla-1 |
| 04/08/2004 | WO2002083169A9 Modified staphylococcal enterotoxins and expression systems therefore |
| 04/08/2004 | WO2002076391B1 Microbial feeds for aquaculture and agriculture |
| 04/08/2004 | WO2002072792A9 Heterologous fusion protein constructs comprising a leishmania antigen |
| 04/08/2004 | WO2002045657A3 Ovarian tumor antigen and methods of use therefor |
| 04/08/2004 | US20040068095 Comprises polypeptide for diagnosis, prevention and treatment of cell proliferative, inflammatory, nervous system and autoimmune diseases |